课题基金 / 基金详情

BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study

BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study
1 型糖尿病的行为、治疗、技术和低血糖风险：BETTER 研究
批准号：
383831
负责人：
Rabasa-Lhoret Rmi
金额：
$109.28万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-11-01 至 2021-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=383831&lang=en
关键词：
Comparative Effectiveness

项目摘要

项目成果

Rabasa-Lhoret Rmi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes requires that patients inject themselves insulin to control the level of sugar in their blood because their pancreas cannot do it anymore. A consequence of this treatment is low blood sugar episodes. This is named hypoglycemia. Severe hyp
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing the burden of hypoglycemia for persons living with type 1 diabetes
Optimizing insulin basal rate adjustments to prevent exercise-induced hypoglycemia in patients with type 1 diabetes using insulin pump therapy
Automated closed-loop control of glucose levels in type 1 diabetes patients with hypoglycemia unawareness
Using artificial pancreas closed-loop systems for the treatment of type 1 diabetes
海外基金